Tectonic Therapeutic (TECX) Shares Outstanding (Weighted Average) (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Shares Outstanding (Weighted Average) data on file, last reported at $18.8 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $18.8 million, up 9.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.8 million (up 9.39% YoY), and the FY2025 annual result was $18.3 million, up 115.81% from the prior year.
• Shares Outstanding (Weighted Average) rose to $18.8 million in Q1 2026 per TECX's latest filing, from $18.3 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $44.5 million in Q3 2023 and troughed at $43695.0 in Q1 2022.
• A 5-year average of $20.0 million and a median of $17.9 million in 2025 frame the typical range for Shares Outstanding (Weighted Average).
• On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 102689.93% in 2022 and fell as far as 99.9% in 2022.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $43.7 million in 2022, then tumbled by 97.1% to $1.3 million in 2023, then jumped by 569.3% to $8.5 million in 2024, then soared by 115.81% to $18.3 million in 2025, then grew by 2.44% to $18.8 million in 2026.
• Business Quant data shows TECX's Shares Outstanding (Weighted Average) at $18.8 million in Q1 2026, $18.3 million in Q4 2025, and $18.2 million in Q3 2025.